[Inhibitory effects of dauricine and anisodamine on production of prostaglandins on bovine cerebral arterial smooth muscle cells].
The effects of dauricine (Dau), aniso amine (Ani), platelet activating factor (PAF), leukotriene C4 (LTC4) and leukotriene D4 (LTD4) on the production of TXB2 and 6-keto-PGF1 alpha (the stable metabolites of TXA2 and PGI2, respectively) in bovine anterior cerebral arterial smooth muscle cells were studied. The normal quantities of TXB2 and 6-keto-PGF1 alpha produced by bovine anterior cerebral arterial smooth muscle cells were 16 +/- 5 and 464 +/- 24 pg/10(5) cells, respectively, when measured by radioimmunoassay (RIA). The levels of TXB2 and 6-keto-PGF1 alpha in bovine anterior cerebral arterial smooth muscle cells decreased significantly when the cells were treated with Dau or Ani over 20 min. Both drugs inhibited the production of TXB2 and 6-keto-PGF1 alpha in dose (1-100 mumol/L) dependent manner. The bovine anterior cerebral arterial smooth muscle cells were stimulated markedly by LTC4 and LTD4 to produce TXB2 and 6-keto-PGF1 alpha on the same condition even at 0.01 mumol/L. When the cells were treated with PAF over 20 min, TXB2 increased significantly, but 6-keto-PGF1 alpha remained unchanged. If the cells were preincubated with Dau or Ani 20 min before PAF, LTC4 or LTD4 stimulation, the production of TXB2 and 6-keto-PGF1 alpha especially TXB2 were inhibited significantly compared with that of PAF, LTC4 or LTD4 group, respectively.(ABSTRACT TRUNCATED AT 250 WORDS)
Zeng
G Q
GQ
Department of Pharmacology, College of Pharmacy, Second Military Medical University, Shanghai, China.
Rui
Y C
YC
D015121:6-Ketoprostaglandin F1 alpha / Q000096:biosynthesis*; D000470:Alkaloids; D000818:Animals; D044182:Benzylisoquinolines; D002417:Cattle; D002478:Cells, Cultured; D002536:Cerebral Arteries / Q000187:drug effects; D007546:Isoquinolines / Q000494:pharmacology*; D009131:Muscle, Smooth, Vascular / Q000166:cytology / Q000187:drug effects* / Q000378:metabolism; D012991:Solanaceous Alkaloids / Q000494:pharmacology*; D044005:Tetrahydroisoquinolines; D013929:Thromboxane B2 / Q000096:biosynthesis*
D000470:Alkaloids; D044182:Benzylisoquinolines; D007546:Isoquinolines; D012991:Solanaceous Alkaloids; D044005:Tetrahydroisoquinolines; C003922:anisodamine; D013929:Thromboxane B2; D015121:6-Ketoprostaglandin F1 alpha; C035934:dauricine